The drug is aimed at patients with severe depression who have shown resistance to two antidepressants they have tried. The U.S. Food & Drug Administration (FDA) has recently granted approval for Spravato, the ketamine-derived nasal spr....

Grab will look to partner with more companies that can provide complementary technology and services to help grow its business in the region Grab, the ride-hailing company headquartered in Singapore, is reportedly planning to raise more fu....